JP2012514120A5 - - Google Patents

Info

Publication number

JP2012514120A5

JP2012514120A5 JP2011544604A JP2011544604A JP2012514120A5 JP 2012514120 A5 JP2012514120 A5 JP 2012514120A5 JP 2011544604 A JP2011544604 A JP 2011544604A JP 2011544604 A JP2011544604 A JP 2011544604A JP 2012514120 A5 JP2012514120 A5 JP 2012514120A5

Authority

JP

Japan

Prior art keywords

bismuth

compound

chemical indicator

composition

acid

Prior art date

2009-12-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 claims description 62
• 230000003287 optical effect Effects 0.000 claims description 52
• 239000000126 substance Substances 0.000 claims description 36
• 238000000034 method Methods 0.000 claims description 29
• 239000002253 acid Substances 0.000 claims description 24
• 229910052797 bismuth Inorganic materials 0.000 claims description 21
• 150000001875 compounds Chemical class 0.000 claims description 20
• JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 19
• -1 bismuth (III) compound Chemical class 0.000 claims description 17
• 239000011230 binding agent Substances 0.000 claims description 15
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 11
• 230000001954 sterilising effect Effects 0.000 claims description 10
• 238000004659 sterilization and disinfection Methods 0.000 claims description 10
• 229920000642 polymer Polymers 0.000 claims description 9
• 239000000758 substrate Substances 0.000 claims description 9
• 125000004432 carbon atom Chemical group C* 0.000 claims description 5
• 125000000962 organic group Chemical group 0.000 claims description 5
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
• 238000004519 manufacturing process Methods 0.000 claims description 4
• 230000002093 peripheral effect Effects 0.000 claims description 4
• QYIGOGBGVKONDY-UHFFFAOYSA-N 1-(2-bromo-5-chlorophenyl)-3-methylpyrazole Chemical compound N1=C(C)C=CN1C1=CC(Cl)=CC=C1Br QYIGOGBGVKONDY-UHFFFAOYSA-N 0.000 claims description 2
• KKMOSYLWYLMHAL-UHFFFAOYSA-N 2-bromo-6-nitroaniline Chemical compound NC1=C(Br)C=CC=C1[N+]([O-])=O KKMOSYLWYLMHAL-UHFFFAOYSA-N 0.000 claims description 2
• YPIFGDQKSSMYHQ-UHFFFAOYSA-N 7,7-dimethyloctanoic acid Chemical compound CC(C)(C)CCCCCC(O)=O YPIFGDQKSSMYHQ-UHFFFAOYSA-N 0.000 claims description 2
• NKESWHPWKOVTBQ-UHFFFAOYSA-K C(C1=CC=CC=C1)(=O)[O-].[Bi+3].C(C(=O)[O-])(=O)[O-].[Bi+3] Chemical compound C(C1=CC=CC=C1)(=O)[O-].[Bi+3].C(C(=O)[O-])(=O)[O-].[Bi+3] NKESWHPWKOVTBQ-UHFFFAOYSA-K 0.000 claims description 2
• RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 2
• 229920002253 Tannate Polymers 0.000 claims description 2
• RBXBKNSKYADFNQ-AHUNZLEGSA-H [Bi+3].[Bi+3].[O-]C(=O)\C=C/C([O-])=O.[O-]C(=O)\C=C/C([O-])=O.[O-]C(=O)\C=C/C([O-])=O Chemical compound [Bi+3].[Bi+3].[O-]C(=O)\C=C/C([O-])=O.[O-]C(=O)\C=C/C([O-])=O.[O-]C(=O)\C=C/C([O-])=O RBXBKNSKYADFNQ-AHUNZLEGSA-H 0.000 claims description 2
• YQYFGORFKUFAJS-UHFFFAOYSA-K [Bi+3].[O-]C(=O)c1cccc2ccccc12.[O-]C(=O)c1cccc2ccccc12.[O-]C(=O)c1cccc2ccccc12 Chemical compound [Bi+3].[O-]C(=O)c1cccc2ccccc12.[O-]C(=O)c1cccc2ccccc12.[O-]C(=O)c1cccc2ccccc12 YQYFGORFKUFAJS-UHFFFAOYSA-K 0.000 claims description 2
• YPQJHZKJHIBJAP-UHFFFAOYSA-N [K].[Bi] Chemical compound [K].[Bi] YPQJHZKJHIBJAP-UHFFFAOYSA-N 0.000 claims description 2
• 150000007513 acids Chemical class 0.000 claims description 2
• 229940072107 ascorbate Drugs 0.000 claims description 2
• 235000010323 ascorbic acid Nutrition 0.000 claims description 2
• 239000011668 ascorbic acid Substances 0.000 claims description 2
• NUMHJBONQMZPBW-UHFFFAOYSA-K bis(2-ethylhexanoyloxy)bismuthanyl 2-ethylhexanoate Chemical compound [Bi+3].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O NUMHJBONQMZPBW-UHFFFAOYSA-K 0.000 claims description 2
• ZDHGGOUPMGSLBR-UHFFFAOYSA-K bis(2-hydroxypropanoyloxy)bismuthanyl 2-hydroxypropanoate Chemical compound [Bi+3].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O ZDHGGOUPMGSLBR-UHFFFAOYSA-K 0.000 claims description 2
• YTLFVJABOBHSFS-UHFFFAOYSA-K bis(diethylcarbamothioylsulfanyl)bismuthanyl n,n-diethylcarbamodithioate Chemical compound CCN(CC)C(=S)S[Bi](SC(=S)N(CC)CC)SC(=S)N(CC)CC YTLFVJABOBHSFS-UHFFFAOYSA-K 0.000 claims description 2
• USBHFGNOYVOTON-UHFFFAOYSA-K bis(dimethylcarbamothioylsulfanyl)bismuthanyl n,n-dimethylcarbamodithioate Chemical compound [Bi+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S USBHFGNOYVOTON-UHFFFAOYSA-K 0.000 claims description 2
• RHGQOMYDGHIKFH-GNOQXXQHSA-K bis[[(z)-octadec-9-enoyl]oxy]bismuthanyl (z)-octadec-9-enoate Chemical compound [Bi+3].CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O RHGQOMYDGHIKFH-GNOQXXQHSA-K 0.000 claims description 2
• JYPVGDJNZGAXBB-UHFFFAOYSA-N bismuth lithium Chemical compound [Li].[Bi] JYPVGDJNZGAXBB-UHFFFAOYSA-N 0.000 claims description 2
• JAONZGLTYYUPCT-UHFFFAOYSA-K bismuth subgallate Chemical compound OC(=O)C1=CC(O)=C2O[Bi](O)OC2=C1 JAONZGLTYYUPCT-UHFFFAOYSA-K 0.000 claims description 2
• 229960000199 bismuth subgallate Drugs 0.000 claims description 2
• ZREIPSZUJIFJNP-UHFFFAOYSA-K bismuth subsalicylate Chemical compound C1=CC=C2O[Bi](O)OC(=O)C2=C1 ZREIPSZUJIFJNP-UHFFFAOYSA-K 0.000 claims description 2
• 229960000782 bismuth subsalicylate Drugs 0.000 claims description 2
• WQZQEQSQBAWPJO-HWEYHMQKSA-K bismuth;(1s,3r)-3-ethoxycarbonyl-2,2,3-trimethylcyclopentane-1-carboxylate Chemical compound [Bi+3].CCOC(=O)[C@]1(C)CC[C@H](C([O-])=O)C1(C)C.CCOC(=O)[C@]1(C)CC[C@H](C([O-])=O)C1(C)C.CCOC(=O)[C@]1(C)CC[C@H](C([O-])=O)C1(C)C WQZQEQSQBAWPJO-HWEYHMQKSA-K 0.000 claims description 2
• RMPWRUZQAKINCP-OPDGVEILSA-K bismuth;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Bi+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RMPWRUZQAKINCP-OPDGVEILSA-K 0.000 claims description 2
• MVPVTQGVSBKPCQ-UHFFFAOYSA-K bismuth;2,2-dimethylpropanoate Chemical compound [Bi+3].CC(C)(C)C([O-])=O.CC(C)(C)C([O-])=O.CC(C)(C)C([O-])=O MVPVTQGVSBKPCQ-UHFFFAOYSA-K 0.000 claims description 2
• YZDVVHSLIPLZLO-UHFFFAOYSA-K bismuth;2-propylpentanoate Chemical compound [Bi+3].CCCC(C([O-])=O)CCC.CCCC(C([O-])=O)CCC.CCCC(C([O-])=O)CCC YZDVVHSLIPLZLO-UHFFFAOYSA-K 0.000 claims description 2
• HGSSJXRWSCRNPH-UHFFFAOYSA-K bismuth;butanoate Chemical compound [Bi+3].CCCC([O-])=O.CCCC([O-])=O.CCCC([O-])=O HGSSJXRWSCRNPH-UHFFFAOYSA-K 0.000 claims description 2
• DSQJVSSALQTTFS-UHFFFAOYSA-J bismuth;potassium;2,3-dihydroxybutanedioate Chemical compound [K+].[Bi+3].[O-]C(=O)C(O)C(O)C([O-])=O.[O-]C(=O)C(O)C(O)C([O-])=O DSQJVSSALQTTFS-UHFFFAOYSA-J 0.000 claims description 2
• KZFDVWZZYOPBQZ-UHFFFAOYSA-K bismuth;potassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KZFDVWZZYOPBQZ-UHFFFAOYSA-K 0.000 claims description 2
• AQHPWSXVBRSMNR-UHFFFAOYSA-K bismuth;propanoate Chemical compound [Bi+3].CCC([O-])=O.CCC([O-])=O.CCC([O-])=O AQHPWSXVBRSMNR-UHFFFAOYSA-K 0.000 claims description 2
• YLQCOSAFPRCDKP-UHFFFAOYSA-J bismuth;sodium;2,3-dihydroxybutanedioate Chemical compound [Na+].[Bi+3].[O-]C(=O)C(O)C(O)C([O-])=O.[O-]C(=O)C(O)C(O)C([O-])=O YLQCOSAFPRCDKP-UHFFFAOYSA-J 0.000 claims description 2
• MFBGWESXOIGYSS-UHFFFAOYSA-K bismuth;triformate Chemical compound [Bi+3].[O-]C=O.[O-]C=O.[O-]C=O MFBGWESXOIGYSS-UHFFFAOYSA-K 0.000 claims description 2
• 239000011248 coating agent Substances 0.000 claims description 2
• 238000000576 coating method Methods 0.000 claims description 2
• SULICOHAQXOMED-YDXPQRMKSA-H dibismuth;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Bi+3].[Bi+3].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O.[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O.[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O SULICOHAQXOMED-YDXPQRMKSA-H 0.000 claims description 2
• SWWKWOMCSSQXRJ-UHFFFAOYSA-H dibismuth;butanedioate Chemical compound [Bi+3].[Bi+3].[O-]C(=O)CCC([O-])=O.[O-]C(=O)CCC([O-])=O.[O-]C(=O)CCC([O-])=O SWWKWOMCSSQXRJ-UHFFFAOYSA-H 0.000 claims description 2
• 239000000463 material Substances 0.000 claims description 2
• 229960003540 oxyquinoline Drugs 0.000 claims description 2
• MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 claims description 2
• AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims description 2
• VZZHAYFWMLLWGG-UHFFFAOYSA-K triazanium;bismuth;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [NH4+].[NH4+].[NH4+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VZZHAYFWMLLWGG-UHFFFAOYSA-K 0.000 claims description 2
• 229940102566 valproate Drugs 0.000 claims description 2
• MSBGPEACXKBQSX-UHFFFAOYSA-N (4-fluorophenyl) carbonochloridate Chemical compound FC1=CC=C(OC(Cl)=O)C=C1 MSBGPEACXKBQSX-UHFFFAOYSA-N 0.000 claims 1
• 150000001621 bismuth Chemical class 0.000 claims 1
• WMWLMWRWZQELOS-UHFFFAOYSA-N bismuth(III) oxide Inorganic materials O=[Bi]O[Bi]=O WMWLMWRWZQELOS-UHFFFAOYSA-N 0.000 claims 1
• TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 description 4
• 229910000416 bismuth oxide Inorganic materials 0.000 description 2
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1